Harrow, Inc. (HROW)
35.38
-0.97
(-2.67%)
USD |
NASDAQ |
Mar 26, 16:00
35.38
0.00 (0.00%)
After-Hours: 18:05
Harrow Enterprise Value : 1.532B for March 25, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Corcept Therapeutics, Inc. | 3.939B |
| Esperion Therapeutics, Inc. | 1.089B |
| Regeneron Pharmaceuticals, Inc. | 73.60B |
| Theravance Biopharma, Inc. | 540.98M |
| Rhythm Pharmaceuticals, Inc. | 5.632B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 6.626M |
| Revenue (Quarterly) | 89.09M |
| Total Expenses (Quarterly) | 82.47M |
| EPS Diluted (Quarterly) | 0.178 |
| Gross Profit Margin (Quarterly) | 79.27% |
| Profit Margin (Quarterly) | 7.44% |
| Earnings Yield | -0.46% |
| Operating Earnings Yield | 2.92% |
| Normalized Earnings Yield | 0.3813 |